Cargando…

Whether adjuvant radiotherapy is desired for postmastectomy patients with T1–T2 tumors and 1–3 positive axillary lymph nodes who received modern systemic therapy?

Detalles Bibliográficos
Autores principales:	Lai, Shih-Fan, Huang, Chiun-Sheng, Kuo, Sung-Hsin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797942/ https://www.ncbi.nlm.nih.gov/pubmed/35117076 http://dx.doi.org/10.21037/tcr.2018.11.18

Ejemplares similares

Is Postmastectomy Radiotherapy Really Needed in Breast Cancer Patients with Many Positive Axillary Lymph Nodes?
por: Marinko, Tanja, et al.
Publicado: (2018)

Effects of postmastectomy radiotherapy on prognosis in different tumor stages of breast cancer patients with positive axillary lymph nodes
por: Jia, Miao-Miao, et al.
Publicado: (2014)

Which Patients Might Benefit from Postmastectomy Radiotherapy in Breast Cancer Patients with T1-2 Tumor and 1-3 Axillary Lymph Nodes Metastasis?
por: Kong, Moonkyoo, et al.
Publicado: (2013)

Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes
por: Yin, Hang, et al.
Publicado: (2017)

Radiotherapy instead of axillary lymph node dissection: evaluation of axillary lymph node dose coverage with whole breast radiotherapy
por: Bukovszky, Bence, et al.
Publicado: (2022)

A Prognostic Risk Stratification Model to Identify Potential Population Benefiting From Postmastectomy Radiotherapy in T1–2 Breast Cancer With 1–3 Positive Axillary Lymph Nodes
por: Hou, Niuniu, et al.
Publicado: (2021)

Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: Is there a role for radiation therapy?
por: Cosar, Rusen, et al.
Publicado: (2011)

Effect of postmastectomy radiotherapy on triple-negative breast cancer with T1-2 and 1-3 positive axillary lymph nodes: a population-based study using the SEER 18 database
por: Zhang, Jie, et al.
Publicado: (2019)

Real-world impact of postmastectomy radiotherapy in T1–2 breast cancer with one to three positive lymph nodes
por: Li, Feng-Yan, et al.
Publicado: (2020)

Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy
por: Xu, Fei-Fei, et al.
Publicado: (2022)

Postmastectomy/Axillary Node Dissection Chyloma: The Additional Value of SPECT/CT Lymphoscintigraphy
por: Thang, Sue Ping, et al.
Publicado: (2014)

Trends in the Application of Postmastectomy Radiotherapy for Breast Cancer With 1 to 3 Positive Axillary Nodes and Tumors ≤5 cm in the Modern Treatment Era: A Retrospective Korean Breast Cancer Society Report
por: Chang, Jee Suk, et al.
Publicado: (2016)

Adjuvant postmastectomy radiotherapy might be associated with better survival in women with heart failure receiving total mastectomy
por: Zhang, Jiaqiang, et al.
Publicado: (2022)

Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy
por: Wu, San-Gang, et al.
Publicado: (2014)

Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1–3 positive lymph nodes: a retrospective study
por: Chitapanarux, Imjai, et al.
Publicado: (2014)

Comparison of Treatment Outcomes between Breast Conserving Surgery Followed by Radiotherapy and Mastectomy Alone in Patients with T1-2 Stage and 1-3 Axillary Lymph Nodes in the Era of Modern Adjuvant Systemic Treatments
por: Kim, Sang-Won, et al.
Publicado: (2016)

Inconsistent radiotherapy effects between primary tumors and axillary lymph nodes
por: Bi, Zhao, et al.
Publicado: (2022)

Dosimetric Comparison of Postmastectomy Radiotherapy Plans for Synchronous Bilateral Breast Cancer, Including Regional Lymph Node Irradiation
por: Wu, Xiuxiu, et al.
Publicado: (2023)

Dose to level I and II axillary lymph nodes and lung by tangential field radiation in patients undergoing postmastectomy radiation with tissue expander reconstruction
por: Russo, James K, et al.
Publicado: (2011)

Assessing Whether Morphological Changes in Axillary Lymph Node Have Already Occurred Prior to Metastasis in Breast Cancer Patients by Ultrasound
por: Guo, Qiang, et al.
Publicado: (2022)

Axillary lymph node dissection combined with radiotherapy for trichilemmal carcinoma with giant lymph node metastasis: A case report
por: Lv, Wenjie, et al.
Publicado: (2022)

Number of Negative Lymph Nodes Can Predict Survival after Postmastectomy Radiotherapy According to Different Breast Cancer Subtypes
por: Wu, San-Gang, et al.
Publicado: (2015)

Postmastectomy Radiotherapy for Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Meattini, Icro, et al.
Publicado: (2014)

Clinical decision making in postmastectomy radiotherapy in node negative breast cancer
por: Barrientos, Rodrigo, et al.
Publicado: (2018)

The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer
por: Zhang, Lei, et al.
Publicado: (2020)

Role of postmastectomy radiation therapy in breast cancer patients with T1–2 and 1–3 positive lymph nodes
por: Cihan, Yasemin Benderli, et al.
Publicado: (2016)

Tuberculosis axillary lymph node coexistent breast cancer in adjuvant treatment: case report
por: Bromberg, Silvio Eduardo, et al.
Publicado: (2015)

Postmastectomy radiation therapy can improve survival for breast cancer patients with 1–3 positive axillary lymph nodes: a retrospective cohort study using the SEER database
por: Yang, Jian, et al.
Publicado: (2021)

Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1–2 tumor and 1–3 axillary lymph node(s) metastasis
por: Su, Yu-Li, et al.
Publicado: (2014)

Evidence-Based Analysis of Lymph Node Transfer in Postmastectomy Upper Extremity Lymphedema
por: Sapountzis, Stamatis, et al.
Publicado: (2013)

Breast Axillary Lymph Node Metastasis
por: Cavalli, Luciane R., et al.
Publicado: (2011)

Axillary lymph node dissection on the run?
por: Maeseele, N, et al.
Publicado: (2017)

Axillary surgery in the case of limited involved axillary lymph nodes
por: Kolberg, Hans-Christian, et al.
Publicado: (2023)

Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases
por: Zheng, Jianwei, et al.
Publicado: (2018)

Whether individualized dose escalation should be recommended for lymph nodes with different sizes in the definitive radiotherapy of cervical cancer?
por: Lv, Xiaojuan, et al.
Publicado: (2022)

10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection
por: Campbell, Ian, et al.
Publicado: (2023)

Ectopic Schistosomiasis Involving Axillary Lymph Nodes
por: Chen, Xia, et al.
Publicado: (2022)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)

Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1–3 Axillary Lymph Node(s) Metastasis
por: Duraker, Nüvit, et al.
Publicado: (2011)

The Prognostic Significance of the Lymph Node Ratio in Axillary Lymph Node Positive Breast Cancer
por: Kim, Ji-Yoon, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cvs76ptt5vb5n1338rb99sik8k